11: Disorders of memory and intellect

Medical Journal of Australia

Volumn 175, Issue 8, 2001, Pages 433-439

  Watson, J D G ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; CHOLINESTERASE INHIBITOR; GALANTAMINE; HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; AMNESIA; ANAMNESIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; DELIRIUM; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE COURSE; HEALTH CARE COST; HUMAN; INTELLECTUAL IMPAIRMENT; LEWY BODY; MULTIINFARCT DEMENTIA; PICK PRESENILE DEMENTIA; PROGNOSIS; REVIEW; RISK FACTOR; SHORT TERM MEMORY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035886513     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143658.x     Document Type: Review

References (41)

1. Delirium in elderly patients: Evaluation and management
2. Clinical assessment of memory disorders in amnesia and dementia
3. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
4. Susceptibility locus for Alzheimer's disease on chromosome 10
5. Association of apolipoprotein E polymorphism with outcome after head injury
6. Vascular risk factors in dementia
7. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study
8. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study
9. Statins and the risk of dementia
10. Lewy body prevalence in the aging brain: Relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei
11. Pick's disease, frontotemporal dementia, and Pick complex: Emerging concepts
12. "Mini-mental state". A practice method for grading the cognitive state of patients for the clinician
13. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
14. The use of positron emission tomography in the clinical assessment of dementia
15. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
16. Methods of screening for dementia: A meta-analysis of studies comparing an informant questionnaire with a brief cognitive test
17. Affective illness, dementia, and pseudodementia
18. Differentiation of dementia and depression by memory tests. A meta-analysis
19. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort
20. Potentially reversible cognitive impairment in patients presenting to a memory disorders clinic
21. A reevaluation of the duration of survival after the onset of dementia
22. Survival of patients with dementia
23. Donepezil for mild and moderate Alzheimer's disease
24. Rivastigmine for Alzheimer's disease
25. Galantamine for Alzheimer's disease
26. Efficacy and safety of nicotine on Alzheimer's disease patients
27. Lecithin for dementia and cognitive impairment
28. Vitamin E for Alzheimer's disease
29. Selegiline for Alzheimer's disease
30. Hormone replacement therapy and cognition: Systematic review and meta-analysis
31. Dehydroepiandrosterone (DHEA) supplementation for cognitive function
32. Aspirin for vascular dementia
33. Pharmacologic management of Alzheimer disease part III: Nonsteroidal antiinflammatory drugs-emerging protective evidence?
34. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia
35. Thioridazine for dementia
36. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia
37. Reality orientation for dementia
38. Reminiscence therapy for dementia
39. A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial